Clinical trial
A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent…
NCT00207740 · Centocor, Inc., Industry · Completed
Key facts
| NCT number | NCT00207740 |
|---|---|
| Title | A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma |
| Official title | A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma |
| Lead sponsor | Centocor, Inc., Industry |
| Collaborators | Centocor BV Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | CNTO148, Placebo |
| Enrollment | 309 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 20, 2012 |
| Countries | Belgium, Bulgaria, Czechia, France, Germany, Hungary, Netherlands, Poland, Sweden, United Kingdom, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: